Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qiong Shou

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Lifetime Data Analysis|March 21, 2016
Analysis of two-phase sampling data with semiparametric additive hazards modelsYanqing Sun, Xiyuan Qian, Qiong Shou, et al.
Trials|December 22, 2014
A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous variablesZhiwei Jiang, Yang Song, Qiong Shou, et al.
Biometrics|December 8, 2021
Semiparametric additive time-varying coefficients model for longitudinal data with censored time originYanqing Sun, Qiong Shou, Peter B Gilbert, et al.
Substance Use & Misuse|August 23, 2013
Personality Risk Factors and Readiness to Change in Mandated and Voluntary College Students Enrolled in an Alcohol Intervention ProgramDonna M Kazemi, Maureen J Levine, Jacek Dmochowski, et al.
Journal of Biopharmaceutical Statistics|April 4, 2023
Application of estimand framework in ICH E9 (R1) to vaccine trialsRong Fu, Hal Li, Xuelong Wang, et al.
Journal of Psychosocial Nursing and Mental Health Services|March 18, 2014
Personality risk for alcohol consequences among college freshmenDonna M Kazemi, Claudia Flowers, Qiong Shou, et al.
Vaccine|February 12, 2018
Evaluation on the persistence of anti-HPV immune responses to the quadrivalent HPV vaccine in Chinese females and males: Up to 3.5 years of follow-upTeng Huang, Youping Liu, Yanping Li, et al.
Vaccine|February 28, 2019
Immunogenicity of pentavalent rotavirus vaccine in Chinese infantsZhaojun Mo, Xiao Ma, Peng Luo, et al.
Vaccine|November 26, 2020
Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in Chinese females aged 9 to 26 years: A phase 3, open-label, immunobridging studyZhuhang Huang, Jianfeng He, Jiali Su, et al.
Vaccine|August 21, 2018
Efficacy of quadrivalent human papillomavirus vaccine against persistent infection and genital disease in Chinese women: A randomized, placebo-controlled trial with 78-month follow-upLihui Wei, Xing Xie, Jihong Liu, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Lifetime Data Analysis|March 21, 2016
Analysis of two-phase sampling data with semiparametric additive hazards modelsYanqing Sun, Xiyuan Qian, Qiong Shou, et al.
Trials|December 22, 2014
A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous variablesZhiwei Jiang, Yang Song, Qiong Shou, et al.
Biometrics|December 8, 2021
Semiparametric additive time-varying coefficients model for longitudinal data with censored time originYanqing Sun, Qiong Shou, Peter B Gilbert, et al.
Substance Use & Misuse|August 23, 2013
Personality Risk Factors and Readiness to Change in Mandated and Voluntary College Students Enrolled in an Alcohol Intervention ProgramDonna M Kazemi, Maureen J Levine, Jacek Dmochowski, et al.
Journal of Biopharmaceutical Statistics|April 4, 2023
Application of estimand framework in ICH E9 (R1) to vaccine trialsRong Fu, Hal Li, Xuelong Wang, et al.
Journal of Psychosocial Nursing and Mental Health Services|March 18, 2014
Personality risk for alcohol consequences among college freshmenDonna M Kazemi, Claudia Flowers, Qiong Shou, et al.
Vaccine|February 12, 2018
Evaluation on the persistence of anti-HPV immune responses to the quadrivalent HPV vaccine in Chinese females and males: Up to 3.5 years of follow-upTeng Huang, Youping Liu, Yanping Li, et al.
Vaccine|February 28, 2019
Immunogenicity of pentavalent rotavirus vaccine in Chinese infantsZhaojun Mo, Xiao Ma, Peng Luo, et al.
Vaccine|November 26, 2020
Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in Chinese females aged 9 to 26 years: A phase 3, open-label, immunobridging studyZhuhang Huang, Jianfeng He, Jiali Su, et al.
Vaccine|August 21, 2018
Efficacy of quadrivalent human papillomavirus vaccine against persistent infection and genital disease in Chinese women: A randomized, placebo-controlled trial with 78-month follow-upLihui Wei, Xing Xie, Jihong Liu, et al.
Pageof 2